Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 17.2
(-0.17%)
CNY 17.2
(-0.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 368.26 Million CNY | 36.54% |
| 2022 | 269.7 Million CNY | 32.05% |
| 2021 | 204.24 Million CNY | 148.29% |
| 2020 | 82.25 Million CNY | 49.38% |
| 2019 | 55.06 Million CNY | -23.5% |
| 2018 | 71.98 Million CNY | 4.98% |
| 2017 | 68.57 Million CNY | 25.76% |
| 2016 | 54.52 Million CNY | 22.14% |
| 2015 | 44.64 Million CNY | 18.13% |
| 2014 | 37.79 Million CNY | 49.57% |
| 2013 | 25.26 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 125.66 Million CNY | 115.67% |
| 2024 Q2 | 158.46 Million CNY | 26.09% |
| 2024 Q3 | 165.6 Million CNY | 4.51% |
| 2023 FY | 368.26 Million CNY | 36.54% |
| 2023 Q2 | 120.73 Million CNY | 57.03% |
| 2023 Q1 | 76.89 Million CNY | 25.41% |
| 2023 Q3 | 112.36 Million CNY | -6.94% |
| 2023 Q4 | 58.27 Million CNY | -48.14% |
| 2022 Q2 | 73.8 Million CNY | 31.87% |
| 2022 Q3 | 78.62 Million CNY | 6.53% |
| 2022 FY | 269.7 Million CNY | 32.05% |
| 2022 Q4 | 61.31 Million CNY | -22.02% |
| 2022 Q1 | 55.96 Million CNY | 59.75% |
| 2021 Q1 | 46.44 Million CNY | 71.56% |
| 2021 FY | 204.24 Million CNY | 148.29% |
| 2021 Q4 | 35.03 Million CNY | -37.88% |
| 2021 Q3 | 56.39 Million CNY | -15.03% |
| 2021 Q2 | 66.36 Million CNY | 42.89% |
| 2020 Q3 | 22.36 Million CNY | -13.02% |
| 2020 Q2 | 25.71 Million CNY | 261.57% |
| 2020 FY | 82.25 Million CNY | 49.38% |
| 2020 Q1 | 7.11 Million CNY | -58.68% |
| 2020 Q4 | 27.07 Million CNY | 21.06% |
| 2019 Q2 | 18.1 Million CNY | 73.8% |
| 2019 FY | 55.06 Million CNY | -23.5% |
| 2019 Q1 | 10.41 Million CNY | -62.21% |
| 2019 Q3 | 9.33 Million CNY | -48.43% |
| 2019 Q4 | 17.2 Million CNY | 84.32% |
| 2018 Q1 | 12.79 Million CNY | -42.43% |
| 2018 FY | 71.98 Million CNY | 4.98% |
| 2018 Q4 | 27.56 Million CNY | 67.01% |
| 2018 Q3 | 16.5 Million CNY | 9.14% |
| 2018 Q2 | 15.12 Million CNY | 18.2% |
| 2017 Q4 | 22.22 Million CNY | 2.09% |
| 2017 FY | 68.57 Million CNY | 25.76% |
| 2017 Q3 | 21.76 Million CNY | 50.72% |
| 2017 Q2 | 14.44 Million CNY | 42.33% |
| 2017 Q1 | 10.14 Million CNY | -61.19% |
| 2016 Q4 | 26.14 Million CNY | 127.32% |
| 2016 Q3 | 11.5 Million CNY | 36.26% |
| 2016 Q2 | 8.44 Million CNY | 25.7% |
| 2016 Q1 | 6.71 Million CNY | -36.96% |
| 2016 FY | 54.52 Million CNY | 22.14% |
| 2015 Q1 | 11.66 Million CNY | 36.6% |
| 2015 Q4 | 10.65 Million CNY | 0.0% |
| 2015 FY | 44.64 Million CNY | 18.13% |
| 2015 Q3 | 10.65 Million CNY | -8.72% |
| 2015 Q2 | 11.66 Million CNY | 0.0% |
| 2014 Q3 | 8.54 Million CNY | -29.26% |
| 2014 Q1 | 12.07 Million CNY | 0.0% |
| 2014 FY | 37.79 Million CNY | 49.57% |
| 2014 Q2 | 12.07 Million CNY | 0.0% |
| 2014 Q4 | 8.54 Million CNY | 0.0% |
| 2013 FY | 25.26 Million CNY | 0.0% |